Ads
related to: tumor immunogenicity
Search results
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Zacks via Yahoo Finance· 2 months agoThis week, J&J JNJ proposed to buy medical device company Shockwave Medical SWAV for approximately...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 weeks agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...
Lava (LVTX) Discontinues Hematological Tumor Study, Shares Fall
Zacks via Yahoo Finance· 12 months agoLava (LVTX) falls 10% due to its decision to discontinue the study on LAVA-051, which is being...
ImmunityBio partners with Serum Institute for BCG vaccines
Pharmaceutical Technology via Yahoo Finance· 1 month agoImmunityBio has entered an exclusive worldwide agreement with the Serum Institute of India to secure...
Theriva Biologics, Inc. (NYSE:TOVX) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoTheriva Biologics, Inc. (NYSE:TOVX) Q3 2023 Earnings Call Transcript November 17, 2023 Operator:...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 23 hours agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine
Benzinga via Yahoo Finance· 1 year agoEvaxion Biotech A/S (NASDAQ: EVAX) and Pantherna Therapeutics GmbH announced a preclinical proof of...
Q2 2023 Theriva Biologics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Manel Cascalló Steven A. Shallcross; CEO, CFO, Treasurer, Corporate Secretary & Director; Theriva Biologics, Inc. James Francis Molloy; MD of Equity Research and Biotechnology & ...
Neoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength
Benzinga via Yahoo Finance· 2 years agoNeoleukin Therapeutics Inc (NASDAQ: NLTX) announced discontinuing the development of NL-201 for...
Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoImunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript November 17, 2023 Operator: Good...
